Lax 510(k) Labeling Rules Alleged By Citizen Petition Citing Lumenis Device
This article was originally published in The Gray Sheet
Labeling for 510(k)-cleared devices should include a notice informing consumers that FDA sign-off is based on applicant claims not verified by the agency, according to an Oct. 4 citizen petition
You may also be interested in...
Lumenis plans to launch a direct-to-consumer advertising campaign by the first quarter of 2003 in support of its ClearLight laser acne treatment system, which received FDA 510(k) clearance on Aug. 19
ESC Medical Systems' $203 mil. purchase of Coherent Medical Group gives it an entry into the high-growth ophthalmic laser market and strengthens the Israeli firm's presence in the U.S.
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.